Cambridge Investment Research Advisors »

Crispr Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 48k 62.59
2023-09-30 $1.0M 23k 45.39
2023-06-30 $1.4M 25k 56.15
2023-03-31 $1.2M 26k 45.24
2022-12-31 $1.1M 27k 40.63
2022-09-30 $1.7M 26k 65.36
2022-06-30 $1.7M 28k 60.75
2022-03-31 $1.4M 22k 62.76
2021-12-31 $1.3M 17k 75.75
2021-09-30 $2.5M 22k 111.92
2021-06-30 $4.4M 28k 161.89
2021-03-31 $2.4M 20k 121.85
2020-12-31 $2.7M 18k 153.10
2020-09-30 $925k 11k 83.66
2020-06-30 $470k 6.4k 73.43
2020-03-31 $250k 5.9k 42.35
2019-12-31 $420k 6.9k 60.89
2019-09-30 $1.5M 31k 47.10
2019-06-30 $1.5M 31k 47.10
2018-09-30 $340k 7.7k 44.33